WeVote
Log In

Bill

Bill

SB 336

Task Force on Responsible Use of Natural Psychedelic Substances - Extension and Membership

2026 Regular Session Introduced by Brian Feldman

Maryland extends task force studying therapeutic and regulatory frameworks for natural psychedelics like psilocybin mushrooms amid expanding clinical research.

Approved by the Governor - Chapter 208
0
WeVote Research Nonpartisan
Bill Summary · SB 336

Legislative bill overview

SB 336 extends Maryland's existing Task Force on Responsible Use of Natural Psychedelic Substances, continuing its mandate to study and make recommendations regarding psilocybin mushrooms and other naturally occurring psychedelics. The bill maintains the task force's investigative work on potential therapeutic applications, regulatory frameworks, and public health considerations related to these substances.

Why is this important

This extension allows Maryland to continue building evidence-based policy on psychedelics at a time when clinical research is expanding nationally and several jurisdictions are exploring decriminalization or therapeutic access models. The task force's recommendations could shape whether Maryland becomes an early adopter of psychedelic-assisted therapies or maintains current restrictions, affecting access for patients with conditions like treatment-resistant depression and PTSD.

Potential points of contention

  • Federal-state conflict: Psilocybin remains a Schedule I controlled substance federally, creating legal complexity for any state-level authorization regardless of task force recommendations
  • Medical evidence standards: Disagreement over whether current clinical research is sufficient to justify therapeutic access versus those wanting longer-term safety data before policy changes
  • Implementation concerns: Questions about how therapeutic access would be regulated, who could administer treatments, and how to prevent recreational use expansion if regulations are loosened

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.